By Momo Yamamoto, Senior Investor Research Analyst, LSN
RESI London returns on December 4, 2025, at the King’s Fund, 11 Cavendish Square, as part of the UK’s largest life science partnering and venture week. Organized by Life Science Nation, RESI (Redefining Every Stage of Investment) brings together early-stage life science and healthcare innovators with hundreds of global investors and strategic partners for a full day of partnering, networking, educational content, and exhibits. Virtual partnering will continue on December 8–9, extending the opportunity to build new relationships.
A highlight of every RESI conference is the investor panel programming, where active investors and strategic partners share candid insights with entrepreneurs on what they look for, how they invest, and how startups can best position themselves for success. This year’s London panels will provide in-depth discussions across some of the most dynamic and fast-growing areas of healthcare innovation.
Partnering with Big Pharma
Building Strategic Relationships to Accelerate Innovation
Securing a Big Pharma partnership can be transformative for early-stage companies. Leaders from major pharmaceutical business development and venture teams will share how they evaluate early partnerships, what they seek in collaborators, and how startups can stand out in a competitive field.
Angels & Family Offices
Flexible Capital and Long-Term Support for Early-Stage Innovators
Family offices and angel investors are increasingly active in healthcare, often bringing patient capital and a long-term perspective. Panelists will discuss what differentiates them from institutional investors, the types of opportunities they prioritize, and how founders can approach these funders successfully.
Medical Devices & Diagnostics
Forward Looking Trends in MedTech Innovations
The medtech sector continues to evolve rapidly, with new technologies driving precision care, digital integration, and improved patient outcomes. Investors in this session will share their outlook on the most exciting innovations, challenges to commercialization, and what makes a device or diagnostic investment-ready.
Digital Health & AI
Harnessing Technology to Transform the Patient Journey
Digital health and AI solutions are reshaping care delivery and patient engagement. This panel will highlight what excites investors most in digital platforms, data-driven technologies, and AI applications—and the key factors that determine which companies will succeed in this fast-moving space.
UK / Europe Ecosystem
Global Opportunities in a Dynamic Innovation Landscape
London and the broader UK/European ecosystem offer unique opportunities for entrepreneurs and investors alike. This panel will feature funders with deep experience across these markets, discussing emerging trends, cross-border deal-making, and strategies for startups seeking to expand globally.
Early Stage Therapeutics
Accelerating Breakthrough Therapies in Pre-Clinical and Early Clinical Stages
Developing therapeutics in early clinical phases presents both great promise and high risk. Investors in this session will share how they assess early-stage science, key milestones that de-risk programs, and where they see the next wave of transformative therapies emerging.
Seed Funds
Catalyzing the Earliest Stages of Healthcare Innovation
Seed funds are critical to getting transformative ideas off the ground. This panel will explore how seed-stage investors evaluate opportunities, balance risk and return, and support entrepreneurs through their first fundraising rounds.
Whether you are developing therapeutics, devices, diagnostics, or digital health technologies, the RESI London investor panels offer a rare opportunity to hear directly from the investors shaping the future of healthcare.
New this year: A combi ticket option is available for RESI London + Genesis 2025, giving you access to both partnering events in one streamlined package. Save £300 with Super Early Bird rates available until October 3.
| Register for RESI London >> |
Next Phase Newsletter 
Leave a comment